Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (3259)	6/8/1999 2:01:00 PM
From: RCMac	of 10280

Regarding the 5% EU "Zyrtec II" royalty, I recall that CEO Barberich has said (at the May '98 annual meeting? at an analysts meeting?) that SEPR expected an average royalty of 10% on the ICE's it out-licensed, with some more and some less. Although I agree that it sounds a reasonable strategy to accept half that in return for being able to use EU trial results, I'd be a little happier if SEPR would say that that's what they're doing, rather than leaving it to us to speculate. I don't think SEPR has even issued a press release about "Zyrtec II" yet. --RCM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next